Bambusa Therapeutics
Boston
About Bambusa Therapeutics
Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $105.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2025)
- Website: bambusatx.com
Industries & Categories
Biotechnology, Health Care, Life Science, Medical
Canonical: https://fsome.com/organization/bambusa-therapeutics-32661 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.